ArticleClinical cardiology2012
Cholesterol screening and management in children and young adults should start early--NO!
Article in Clinical cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Universal Lipid Screening Among 9- to 11-Year-Old Children: Screening Results and Physician Management.Clinical pediatrics · 2022Article
- Parental Knowledge and Attitudes About Universal Lipid Screening Among Children Aged 9 to 11 Years.Clinical pediatrics · 2020Article
- Serum Lipid Profile, Prevalence of Dyslipidaemia, and Associated Risk Factors Among Northern Mexican Adolescents.Journal of pediatric gastroenterology and nutrition · 2016Article
- Does true Gleason pattern 3 merit its cancer descriptor?Nature reviews. Urology · 2016Review
- A systematic review and meta-analysis on screening lipid disorders in the pediatric age group.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015Review
- Prevalence of dyslipidaemia and associated risk factors among Balearic Islands adolescents, a Mediterranean region.European journal of clinical nutrition · 2015Article
- Management of hypercholesterolemia in children.Paediatric drugs · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2011, an expert panel from the National Heart, Lung, and Blood Institute released recommendations for universal lipid screening and treatment of high cholesterol in children. There is no evidence that universal screening will help children lead longer, healthier lives. These recommendations will, however, fuel the epidemic of overtreatment that is currently threatening our healthcare system and our patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.